H 2 S Donor SPRC Ameliorates Ischemic Stroke by Upregulating CD24
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70243 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Chenye Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, the Key Laboratory of Smart Drug Delivery (Ministry of Education), School of Pharmacy, Minhang Hospital, Fudan University…. Hauptthemen laut MEDLINE: Ischemic Stroke, CD24 Antigen, Hydrogen Sulfide, Cysteine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Commission of Shanghai Municipality, Macau Science and Technology Development Fund.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Ischemic stroke is well‐known for its high mortality and morbidity, but its treatment remains to be explored due to the current limitations. For example, severe neuroinflammation occurs after ischemic stroke; however, effective neuroinflammatory inhibitors are still lacking. Thus, the development of new therapeutic targets of inhibiting neuroinflammation is urgent. CD24 is a small heavy glycosylated protein, which plays a critical role in neural development and acts as an inflammatory suppressor in tumors and autoimmune diseases. But the role of CD24 in ischemic stroke remains unknown.
Aims
The role of CD24 in ischemic stroke should be explored. Additionally, the potential relationship between the H 2 S donor, S‐propargyl‐cysteine (SPRC) and CD24 in ischemic stroke should be revealed.
Methods
Mechanism studies have been performed both in vitro and in vivo to verify the CD24‐mediated inflammation and migration. SPRC has been applied to treat ischemic stroke, and its potential association with CD24 has been studied.
Results
The overexpression of CD24 can inhibit the nuclear factor kappa B (NF‐κB) inflammatory signaling pathway and promote the migration ability of M2 microglia cells via Src/Fak/Pyk2 signaling pathway in an inflammatory model of BV2 cells. SPRC can upregulate the level of endogenous H 2 S via cystathionase‐β‐synthase (CBS) and it indirectly plays a role in upregulating CD24.
Conclusions
CD24 could be a potential target of inhibiting neuroinflammation. SPRC reduces inflammation in ischemic stroke by regulating the CD24/Iκ‐Bα/NF‐κB inflammatory signaling pathway and improves the migration ability of M2 microglia via CD24/Src/Fak/Pyk2 signaling pathway, which further alleviates the inflammatory response at the lesion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, the Key Laboratory of Smart Drug Delivery (Ministry of Education), School of Pharmacy, Minhang Hospital, Fudan University, Shanghai, China.
- School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrializtion, Macau University of Science and Technology, Macau, China.
- School of Pharmacy, Provincial Key Laboratory of Inflammation and Molecular Drug Target, Institute for Translational Neuroscience, Affiliated Hospital 2 of Nantong University, Centre for Neural Developmental and Degener…
ORCID-Profile: Chenye Wang, Qing Zhu, Yicheng Mao
Förderung
- The Science and Technology Commission of Shanghai Municipality
- Macau Science and Technology Development Fund
Zitieren
APA
Wang, C., Li, S., Li, Q., Xi, H., Li, J., Zhu, Q., Wu, P., Zhu, Y. Z., & Mao, Y. (2025). H 2 S Donor SPRC Ameliorates Ischemic Stroke by Upregulating CD24. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70243
Vancouver
Wang C, Li S, Li Q, Xi H, Li J, Zhu Q, et al. H 2 S Donor SPRC Ameliorates Ischemic Stroke by Upregulating CD24. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70243
BibTeX
@article{Wang2025,
author = {Wang, Chenye and Li, Sha and Li, Qixiu and Xi, Haiyan and Li, Jiejia and Zhu, Qing and Wu, Pinwen and Zhu, Yi-Zhun and Mao, Yicheng},
title = {H 2 S Donor SPRC Ameliorates Ischemic Stroke by Upregulating CD24},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70243}
}
EUVIMED